National Association of Testing Authorities, Australia
Scope of Accreditation
Eastern Health Pathology
Site
Box Hill Hospital Laboratory
Accreditation No.
2971
Site No.
2964
Date of Accreditation
17 Aug 1990
Address
Level 4, Building B, 8 Arnold Street
Box Hill, VIC 3128
Australia
Contact
Ms Rachal McKay P: +61 (03) 98953565
Availability
Services available to external clients
Supervision
GX (General)
Scope of Accreditation
Anatomical Pathology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
24 Jul 2027
Last Activity Date
26 Jul 2024
| Service | Product | Determinant |
|---|---|---|
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations of body fluids, exudates, washings and brushings from non-squamous mucosal sites for the detection of malignancy | Other body fluids; Sputum; Urine; Washings or brushings from other sites | Cytological examination; Review and reporting of cytology samples |
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations of nipple discharge or smears from squamous mucosal sites for the detection of cancerous or precancerous changes | Skin smears | Cytological examination; Review and reporting of cytology samples |
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations on samples obtained via fine needle aspiration biopsy | Fine needle aspirates (FNA) | Cytological examination; Review and reporting of fine needle aspiration samples |
| Anatomical pathology - Tissue pathology - Examination of biopsy material | Formalin-fixed tissue; Fresh tissue; Smears | Review and reporting of biopsy material to identify or exclude morphological abnormalities |
| Anatomical pathology - Tissue pathology - Gene probes using paraffin in situ hybridisation techniques (chromogenic/silver) | Formalin-fixed paraffin-embedded (FFPE) tissues | Detection of nucleic acid targets - Various |
| Anatomical pathology - Tissue pathology - Immediate frozen section diagnosis | Fresh tissue | Intra-operative consultation and examination of biopsy material |
| Anatomical pathology - Tissue pathology - Immunohistochemical (immunofluorescence) investigation | Formalin-fixed paraffin-embedded (FFPE) tissues | Detection of antigenic targets - Various |
| Anatomical pathology - Tissue pathology - Immunohistochemical investigation | Fixed cytological smears; Formalin-fixed paraffin-embedded (FFPE) tissues | Detection of antigenic targets - Various |
Chemical Pathology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
24 Jul 2027
Last Activity Date
26 Jul 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Analysis of calculus | Renal calculi | Ammonium; Calcium; Carbonate; Cystine; Magnesium; Oxalate; Phosphate; Uric acid |
| Chemical pathology - Analysis of drugs for toxicological (non-legal) purposes and ingested or absorbed toxic chemicals | Plasma; Serum | Ethanol |
| Urine | Amphetamines; Barbiturates; Benzodiazepines; Cannabis; Cocaine; Methadone; Opiates | |
| Chemical pathology - Detection and/or quantitation of drugs for therapeutic monitoring | Plasma; Serum | Carbamazepine; Gentamicin (cidomycin, septopal, genticyn, garamycin); Lithium; Paracetamol (acetaminophen); Phenytoin (dilantin); Salicylate; Tacrolimus; Theophylline; Valproate (valproic acid, epilim); Vancomycin |
| Digoxin | ||
| Serum | Methotrexate | |
| Chemical pathology - Detection and/or quantitation of tumour markers | Ascitic fluid; Peritoneal dialysis fluid; Pleural fluid | CA19-9 antigen (CA19-9); Carcinoembryonic antigen (CEA) |
| Plasma; Serum | β2-Microglobulin (B2M) | |
| CA125 antigen (CA125); CA15-3 antigen (CA15-3); CA19-9 antigen (CA19-9); Carcinoembryonic antigen (CEA); Prostate specific antigen (PSA); Prostate specific antigen (PSA) - Free; Thyroglobulin; α-Fetoprotein (AFP) | ||
| Chemical pathology - Determination of hormones and hormone binding proteins (other than thyroid function tests) | Plasma; Serum | C-peptide; Cortisol; Follicle stimulating hormone (FSH); Insulin; Luteinising hormone (LH); Oestradiol; Parathyroid hormone (PTH); Progesterone; Prolactin; Sex hormone binding globulin (SHBG); Testosterone |
| Adrenocorticotropic hormone (ACTH) | ||
| Chemical pathology - Diagnosis and management of diabetes mellitus | Blood | Glycated haemoglobin (HbA1c) |
| Chemical pathology - Further investigation of cardiac function | Plasma; Serum | N-Terminal-pro b-type natriuretic peptide (NT-proBNP); Troponin T |
| Chemical pathology - Further investigation of lipid profiles for diagnosis of types III and IV hyperlipidaemia | Plasma; Serum | HDL - Quantitation |
| Chemical pathology - Further investigation of renal and/or hepatic function | Plasma; Serum | Haptoglobins |
| Serum | Bile acids; Prealbumin | |
| Caeruloplasmin | ||
| Chemical pathology - Haem related pigments and precursors (excluding porphyria) | Cerebrospinal fluid (CSF) | Xanthochromia |
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Ascitic fluid | Amylase |
| Ascitic fluid; Peritoneal dialysis fluid; Pleural fluid | Albumin; Cholesterol - Total; Creatinine; Glucose; Lactate; Lactate dehydrogenase (LDH); Lipase; Potassium; Protein - Total; Sodium; Triglycerides; Urate; Urea | |
| Cerebrospinal fluid (CSF) | Glucose; Protein - Total | |
| Plasma; Serum | Ammonia | |
| Alanine aminotransferase; Albumin; Alkaline phosphatase; Amylase; Aspartate aminotransferase; Bicarbonate; Bilirubin - Any fractions; Bilirubin - Total; C-reactive protein (CRP); Calcium - Total; Chloride; Cholesterol - Total; Creatine kinase; Creatinine; Glucose; High sensitivity C-reactive protein (CRP); Lactate; Lactate dehydrogenase (LDH); Lipase; Magnesium; Phosphate; Potassium; Protein - Total; Sodium; Triglycerides; Urate; Urea; γ-Glutamyltransferase | ||
| Serum; Urine | Osmolality | |
| Urine | Albumin; Calcium - Total; Chloride; Creatinine; Magnesium; Phosphate; Potassium; Protein - Total; Sodium; Urate; Urea | |
| Chemical pathology - Investigation for folate deficiency | Plasma; Serum | Folate |
| Chemical pathology - Investigation of maternal markers for pre-eclampsia | Serum | FMS-like tyrosine kinase 1 - Soluble; Placental growth factor (PGF, PLGF); sFlt-1/PlGF ratio |
| Chemical pathology - Iron studies | Plasma; Serum | Ferritin; Iron; Transferrin |
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Calcium; Carboxyhaemoglobin; Chloride; Deoxyhaemoglobin (HHb); Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
| Chemical pathology - Quantitation of precursor and intermediary metabolites | Plasma | Amino acids |
| Chemical pathology - Quantitation of vitamins | Plasma; Serum | Cobalamin (vitamin B12); Holotranscobalamin (active vitamin B12); Vitamin D |
| Chemical pathology - Tests for thyroid function | Plasma; Serum | Thyroxine (T4) - Free |
| Thyroid stimulating hormone (TSH); Triiodothyronine (T3) - Free | ||
| Immunopathology - Detection and/or quantitation and/or characterisation of autoantibodies | Plasma; Serum | Rheumatoid factor |
| Serum | Anti-thyroglobulin antibodies (Tg); Anti-thyroid peroxidase antibodies (TPO); Anti-thyroid stimulating hormone receptor antibodies (TSHRAb) | |
| Immunopathology - Quantitation of complement proteins | Plasma; Serum | Complement components C3 and C4 |
| Immunopathology - Quantitative and/or qualitative investigation of proteins | Serum | Detection and quantitation of free kappa and free lambda light chains; α1-Antitrypsin |
| Serum; Urine | Detection of Bence Jones proteins; Monoclonal proteins | |
| Immunopathology - Quantitative investigations of immunoglobulins and immunoglobulins subclasses | Plasma; Serum | Total immunoglobulin A; Total immunoglobulin E; Total immunoglobulin G; Total immunoglobulin M |
| Serum | Immunoglobulin subclasses | |
| Infertility and pregnancy tests including assisted reproductive technology - Diagnosis of pregnancy | Plasma; Serum | Human chorionic gonadotropin (hCG) |
Emergency Department
ISO 15189 (2022)
Human Pathology
Medicare expiry date
24 Jul 2027
Last Activity Date
26 Jul 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Calcium; Carboxyhaemoglobin; Chloride; Deoxyhaemoglobin (HHb); Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; Total carbon dioxide (TCO2); pH |
Flow Cytometry
ISO 15189 (2022)
Human Pathology
Medicare expiry date
24 Jul 2027
Last Activity Date
26 Jul 2024
| Service | Product | Determinant |
|---|---|---|
| Immunopathology - Characterisation of leucocyte surface antigens (including immunophenotyping) | Blood | CD19; CD3; CD4; CD45; CD56; CD8 |
| CD14; CD16; CD235a; CD33; CD45; CD59; CD66abce; Fluorescein-labelled proaerolysin (FLAER) | ||
| Blood; Bone marrow; Fresh tissue | CD10; CD11c; CD16; CD19; CD20; CD200; CD22; CD23; CD25; CD3; CD4; CD5; CD56; CD7; CD79b; CD8; FMC7; Kappa light chains; Lambda light chains | |
| CD10; CD117; CD11b; CD13; CD138; CD14; CD15; CD19; CD1a; CD2; CD20; CD22; CD235a; CD3; CD33; CD34; CD38; CD4; CD41; CD45; CD56; CD7; CD79αcy; CD8; HLA-DR antigen; Myeloperoxidase; Terminal deoxynucleotidyl transferase (TdT) | ||
| Blood; Disaggregated tissues specimen | Assessment of lymphoid cell populations; Assessment of myeloid cell populations; CD138; CD38; CD4; CD8; Plasma cell; Total leucocyte number; Total lymphocyte number |
Haematology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
24 Jul 2027
Last Activity Date
26 Jul 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Analysis of drugs for toxicological (non-legal) purposes and ingested or absorbed toxic chemicals | Blood; Swabs; Urine | Snake venom detection |
| Haematology - Assessment of haemolysis or metabolic enzymes (red cell enzyme assays) | Blood | Glucose-6-phosphate dehydrogenase (G6PD) |
| Haematology - Bone marrow examination | Bone marrow | Examination of aspirated material; Histological examination |
| Haematology - Examination of blood films by special staining | Blood | Malaria |
| Haematology - Foetal haemoglobin in maternal circulation | Blood | Detection and quantitation of foetal red cells |
| Haematology - Full blood examination | Blood | Morphology |
| Differential number; Erythrocyte count (red blood cell count, RBCC); Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Leucocyte count (white blood cell count, WBCC); Platelet count; Red blood cell distribution width (RDW); Red blood cell index or indices; Reticulocytes | ||
| Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Plasma | Activated partial thromboplastin time (APTT); Anti-Xa - Apixaban; Anti-Xa - Dabigatran; Anti-Xa - Fondaparinux; Anti-Xa - Rivaroxaban; Anti-thrombin III; D-dimer; Factor II; Factor IX; Factor V; Factor VII; Factor VIII; Factor X; Factor XI; Factor XII; Fibrinogen; Heparin assay; International normalised ratio (INR); Lupus anticoagulant; Protein C and protein S; Thrombin time (TT); Von Willebrand factor (vWF); Von Willebrand factor (vWF) activity - Ristocetin co-factor assay; Von Willebrand factor (vWF) antigen - Quantitation |
| Platelet function (PFA) | ||
| Von Willebrand collagen binding assay | ||
| Haematology - Limited blood examination | Blood | Erythrocyte (RBC) sedimentation rate (ESR) |
| Immunohaematology - Blood group antibody detection | Blood | Other blood group systems |
| Immunohaematology - Blood grouping | Blood | ABO; RhD |
| Immunohaematology - Determination of compatibility of blood donor units | Blood | Direct antiglobulin test (DAT, direct Coombs test); Examination for blood group antibodies; Group checks of patient and donor; Identification of detected antibodies |
| Immunohaematology - Identification and quantitation of blood group antibodies | Blood | Antibody absorption; Antibody elution; Antibody titration; Direct antiglobulin test (DAT, direct Coombs test) |
| Immunohaematology - Investigation of blood transfusion reactions | Blood products | Antibodies |
| Immunohaematology - Issue and release of blood and blood product for transfusion | Blood; Cryoprecipitate; Fresh frozen plasma (FFP); Platelets | Issue and release of blood and blood products for transfusion |
| Immunohaematology - Storage and distribution of blood and blood components | Blood; Cryoprecipitate; Fresh frozen plasma (FFP); Platelets | Issue and release of blood and blood products for transfusion |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (protozoan parasites) | Blood | Malaria |
| Microbiology - Parasitology - Detection of ova, cysts and parasites | Blood | Malaria |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Blood; Plasma; Serum | Infectious mononucleosis |
Intensive Care Unit
ISO 15189 (2022)
Human Pathology
Medicare expiry date
24 Jul 2027
Last Activity Date
26 Jul 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Calcium; Carboxyhaemoglobin; Chloride; Deoxyhaemoglobin (HHb); Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Microbiology
ISO 15189 (2022)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
Medicare expiry date
24 Jul 2027
Last Activity Date
26 Jul 2024
| Service | Product | Determinant |
|---|---|---|
| Infertility and pregnancy tests including assisted reproductive technology - Semen analysis for post vasectomy and/or examination of cervical mucus | Semen | Presence of spermatozoa |
| Microbiology - Bacteriology - Detection of pathogenic bacteria | Aspirates; Blood; Cerebrospinal fluid (CSF); Ear swabs; Eye swabs; Fluids; General swabs; Genital specimens; Nasal swabs; Nasopharyngeal swabs; Respiratory specimens; Sputum; Synovial fluid; Throat swabs; Tissues; Wound swabs | Bacteria; Blood; Crystals; Cultured pathogens identification; Epithelial cells; Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC); Pathogenic identification and antibiotic susceptibility |
| Aspirates; Blood; Cerebrospinal fluid (CSF); Ear swabs; Eye swabs; Fluids; General swabs; Genital swabs; Nasal swabs; Respiratory specimens; Sputum; Throat swabs; Tissues; Wound swabs | Antibiotic susceptibility; Cultured pathogens identification; Pathogenic identification and antibiotic susceptibility; Pathogenic microorganisms | |
| Bacterial isolates | Pathogenic identification | |
| Blood | Bacteria; Pathogenic microorganisms | |
| Faeces | Antibiotic susceptibility; Bacteria; Cultured pathogens identification; Pathogenic identification and antibiotic susceptibility | |
| Urine | Epithelial cells; Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC) | |
| Legionella antigen; Streptococcus pneumoniae antigen | ||
| Blood; Glucose; Haemoglobin (Hb); Leucocytes (white blood cells, WBC); Nitrite; Pathogenic microorganisms; Proteins; pH | ||
| Antibiotic susceptibility; Bacteria; Blood; Cultured pathogens identification; Glucose; Haemoglobin (Hb); Leucocytes (white blood cells, WBC); Nitrite; Pathogenic identification and antibiotic susceptibility; Proteins; pH | ||
| Microbiology - Bacteriology - Detection of pathogenic bacteria for epidemiological infection control surveillance | Wounds | Carbapenem resistant Enterobacteriaceae (CRE); Methicillin resistant Staphylococcus aureus (MRSA); Vancomycin resistant Enterococci (VRE) |
| Microbiology - Environmental investigations and/or infection control (Clinical non-human testing) | Air; Blood transfusion bags; Gastrointestinal endoscopes; Vascular catheter tips | Bacterial growth - Sterility; Bacterial organism identification - Acinetobacter; Bacterial organism identification - Legionella spp.; Bacterial organism identification - Carbapenem resistant Enterobacteriaceae (CRE); Bacterial organism identification - Methicillin-resistant Staphylococcus aureus (MRSA); Bacterial organism identification - Vancomycin-resistant Enterococcus (VRE) |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (bacteria) | Faeces; Genital swabs | Chlamydia trachomatis; Clostridioides difficile; Neisseria gonorrhoeae; Trichomonas vaginalis |
| Nasopharyngeal swabs | Bordetella spp. | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (mycobacteria) | Sputum | Mycobacterium tuberculosis |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Nasal swabs; Nasopharyngeal swabs; Throat swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | ||
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | ||
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | ||
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | ||
| Influenza A virus; Influenza B virus; Respiratory syncytial virus (RSV) A/B | ||
| Nasopharyngeal aspirate; Nasopharyngeal swabs | Influenza A virus; Influenza B virus; Respiratory syncytial virus (RSV) A/B | |
| Nasopharyngeal swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Adenovirus; Enterovirus; Human metapneumovirus; Influenza A virus; Influenza B virus; Parainfluenza virus type 1/2/3/4; Respiratory syncytial virus (RSV) A/B; Rhinovirus; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | ||
| Influenza A virus; Influenza B virus; Respiratory syncytial virus (RSV) | ||
| Serum | Hepatitis B virus (HBV) viral load | |
| Microbiology - Molecular biology - Surveillance programme for the detection of microbial nucleic acids (viruses) in accordance with Commonwealth and/or State Health protocols | Saliva | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) |
| Saliva suck swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Microbiology - Mycobacteriology - Detection and identification of mycobacteria | Respiratory specimens; Sputum | Mycobacteria identification |
| Microbiology - Mycology - Detection of dermatophytes and other fungi causing cutaneous disease | Nails; Skin scrapings | Dermatophyte identification |
| Microbiology - Mycology - Detection, isolation and/or identification of yeasts and/or fungal elements | Cerebrospinal fluid (CSF) | Cryptococcus antigen |
| Nails; Skin scrapings | Fungi identification | |
| Fungi identification; Fungi susceptibility | ||
| Nails; Skin scrapings; Sputum | Fungi identification | |
| Microbiology - Parasitology - Detection of ova, cysts and parasites | Faeces | Cryptosporidia; Giardia spp.; Parasites |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Plasma; Serum | Hepatitis B virus core antibody (anti-HBc) - Total; Syphilis Treponema pallidum antibody |
| Hepatitis A virus (HAV); Hepatitis A virus antibody (anti-HAV) - IgG; Hepatitis A virus antibody (anti-HAV) - IgM; Hepatitis B virus surface antibody (anti-HBs); Hepatitis B virus surface antigen (HBs Ag); Hepatitis C virus antibody (anti-HCV) - IgG; Human immunodeficiency virus (HIV) p24 antigen; Human immunodeficiency virus type 1/2 (HIV-1/2) 1/2 antibodies; Rubella IgG antibody; Toxoplasma | ||
| Syphilis Treponema pallidum antibody | ||
| Cytomegalovirus (CMV); Epstein-Barr virus; Hepatitis B virus surface antigen (HBs Ag); Measles virus; Mumps virus; Toxoplasma; Varicella zoster virus (VZV) | ||
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) antibody | ||
| Serum | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) antibody | |
| Microbiology - Virology - Detection of pathogenic viruses | Faeces; Nasopharyngeal swabs | Adenovirus; Rotavirus |
Operating Theatre
ISO 15189 (2022)
Human Pathology
Medicare expiry date
24 Jul 2027
Last Activity Date
26 Jul 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Calcium; Carboxyhaemoglobin; Chloride; Deoxyhaemoglobin (HHb); Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Special Care Nursery
ISO 15189 (2022)
Human Pathology
Medicare expiry date
24 Jul 2027
Last Activity Date
26 Jul 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Blood | Glucose |
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Base excess; Bicarbonate; Lactate; Oxygen saturation (sO2); Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Total carbon dioxide (TCO2); pH |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
2971
Site No.
2964
Print date
25 Nov 2024
END OF SCOPE